Zeaxanthin ameliorates high glucose-induced mesangial cell apoptosis through inhibiting oxidative stress via activating AKT signalling-pathway

Biomedicine and Pharmacotherapy

Volumn 90, Issue , 2017, Pages 796-805

  Ying, Changjiang ^a   Chen, Lei ^a   Wang, Shanshan ^a   Mao, Yizhen ^a   Ling, Hongwei ^a   Li, Wei ^a   Zhou, Xiaoyan ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cleaved caspase 3; Glomerular mesangial cells; p AKT; Zeaxanthin

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CASPASE 3; CHOLECYSTOKININ OCTAPEPTIDE; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; MALONALDEHYDE; PROTEIN BAX; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; ZEAXANTHIN; 2-(4-MORPHOLINYL)-8-PHENYL-4H-1-BENZOPYRAN-4-ONE; CHROMONE DERIVATIVE; MORPHOLINE DERIVATIVE; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASSAY; CELL DAMAGE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FLOW CYTOMETRY; INJURY; MESANGIUM CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; DRUG EFFECTS; METABOLISM; PHOSPHORYLATION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CELLS, CULTURED; CHROMONES; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3 BETA; MESANGIAL CELLS; MORPHOLINES; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; ZEAXANTHINS;

EID: 85017514865     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2017.04.013     Document Type: Article

References (39)

1. [1] Reidy, K., Kang, H.M., Hostetter, T., Susztak, K., Molecular mechanisms of diabetic kidney disease. J. Clin. Invest. 124:6 (2014), 2333–2340.
2. [2] Kikkawa, R., Koya, D., Haneda, M., Progression of diabetic nephropathy. Am. J. Kidney. Dis. 41:3 Suppl. 1 (2003), S19–21.
3. [3] Harris, R.D., Steffes, M.W., Bilous, R.W., Sutherland, D.E., Mauer, S.M., Global glomerular sclerosis and glomerular arteriolar hyalinosis in insulin dependent diabetes. Kidney Int. 40:1 (1991), 107–114.
4. [4] Lemley, K.V., Abdullah, I., Myers, B.D., Meyer, T.W., Blouch, K., Smith, W.E., et al. Evolution of incipient nephropathy in type 2 diabetes mellitus. Kidney Int. 58:3 (2000), 1228–1237.
5. [5] Kang, B.P., Frencher, S., Reddy, V., Kessler, A., Malhotra, A., Meggs, L.G., High glucose promotes mesangial cell apoptosis by oxidant-dependent mechanism. Am. J. Physiol. Renal. Physiol. 284:3 (2003), F455–466.
6. [6] Jha, J.C., Banal, C., Chow, B.S., Cooper, M.E., Jandeleit-Dahm, K., Diabetes and kidney disease: role of oxidative stress. Antioxid. Redox. Signal. 25:12 (2016), 657–684.
7. [7] Coughlan, M.T., Sharma, K., Challenging the dogma of mitochondrial reactive oxygen species overproduction in diabetic kidney disease. Kidney. Int. 90:2 (2016), 272–279.
8. [8] Hussein, M.M., Mahfouz, M.K., Effect of resveratrol and rosuvastatin on experimental diabetic nephropathy in rats. Biomed. Pharmacother. 82 (2016), 685–692.
9. [9] Ying, C., Zhou, X., Chang, Z., Ling, H., Cheng, X., Li, W., Blood glucose fluctuation accelerates renal injury involved to inhibit the AKT signaling pathway in diabetic rats. Endocrine 53:1 (2016), 81–96.
10. [10] Kitada, M., Kume, S., Imaizumi, N., Koya, D., Resveratrol improves oxidative stress and protects against diabetic nephropathy through normalization of Mn-SOD dysfunction in AMPK/SIRT1-independent pathway. Diabetes 60:2 (2011), 634–643.
11. [11] He, T., Guan, X., Wang, S., Xiao, T., Yang, K., Xu, X., et al. Resveratrol prevents high glucose-induced epithelial-mesenchymal transition in renal tubular epithelial cells by inhibiting NADPH oxidase/ROS/ERK pathway. Mol. Cell. Endocrinol. 402 (2015), 13–20.
12. [12] Shang, G., Tang, X., Gao, P., Guo, F., Liu, H., Zhao, Z., et al. Sulforaphane attenuation of experimental diabetic nephropathy involves GSK-3 beta/Fyn/Nrf2 signaling pathway. J. Nutr. Biochem. 26:6 (2015), 596–606.
13. [13] Manikandan, R., Thiagarajan, R., Goutham, G., Arumugam, M., Beulaja, M., Rastrelli, L., et al. Zeaxanthin and ocular health, from bench to bedside. Fitoterapia 109 (2016), 58–66.
14. [14] Gong, X., Rubin, L.P., Role of macular xanthophylls in prevention of common neovascular retinopathies: retinopathy of prematurity and diabetic retinopathy. Arch. Biochem. Biophys. 572 (2015), 40–48.
15. [15] Kato, M., Yuan, H., Xu, Z.G., Lanting, L., Li, S.L., Wang, M., et al. Role of the Akt/FoxO3a pathway in TGF-beta1-mediated mesangial cell dysfunction: a novel mechanism related to diabetic kidney disease. J. Am. Soc. Nephrol. 17:12 (2006), 3325–3335.
16. [16] Jain, S.K., Croad, J.L., Velusamy, T., Rains, J.L., Bull, R., Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFkappaB, Akt, and Glut-2 in livers of zucker diabetic fatty rats. Mol. Nutr. Food Res. 54:9 (2010), 1371–1380.
17. [17] Othman, E.M., Hintzsche, H., Stopper, H., Signaling steps in the induction of genomic damage by insulin in colon and kidney cells. Free Radic. Biol. Med. 68 (2014), 247–257.
18. [18] Maurer, U., Preiss, F., Brauns-Schubert, P., Schlicher, L., Charvet, C., GSK-3 – at the crossroads of cell death and survival. J. Cell. Sci. 127:Pt. 7 (2014), 1369–1378.
19. [19] Paeng, J., Chang, J.H., Lee, S.H., Nam, B.Y., Kang, H.Y., Kim, S., et al. Enhanced glycogen synthase kinase-3beta activity mediates podocyte apoptosis under diabetic conditions. Apoptosis 19:12 (2014), 1678–1690.
20. [20] Lin, C.L., Wang, J.Y., Huang, Y.T., Kuo, Y.H., Surendran, K., Wang, F.S., Wnt/beta-catenin signaling modulates survival of high glucose-stressed mesangial cells. J. Am. Soc. Nephrol. 17:10 (2006), 2812–2820.
21. [21] Nakajima, Y., Shimazawa, M., Otsubo, K., Ishibashi, T., Hara, H., Zeaxanthin, a retinal carotenoid, protects retinal cells against oxidative stress. Curr. Eye Res. 34:4 (2009), 311–318.
22. [22] Wu, D., Peng, F., Zhang, B., Ingram, A.J., Gao, B., Krepinsky, J.C., Collagen I induction by high glucose levels is mediated by epidermal growth factor receptor and phosphoinositide 3-kinase/Akt signalling in mesangial cells. Diabetologia 50 (2007), 2008–2018.
23. [23] Zhang, Z., Li, J., Yang, L., Chen, R., Yang, R., Zhang, H., et al. The cytotoxic role of intermittent high glucose on apoptosis and cell viability in pancreatic beta cells. J. Diabetes. Res., 2014, 2014, 712781.
24. [24] Zhao, Y., Lu, N., Li, H., Zhang, Y., Gao, Z., Gong, Y., High glucose induced human umbilical vein endothelial cell injury: involvement of protein tyrosine nitration. Mol. Cell. Biochem. 311:1–2 (2008), 19–29.
25. [25] Fan, Y.P., Weiss, R.H., Exogenous attenuation of p21 (Waf1/Cip1) decreases mesangial cell hypertrophy as a result of hyperglycemia and IGF-1. J. Am. Soc. Nephrol. 15:3 (2004), 575–584.
26. [26] Mishra, R., Emancipator, S.N., Kern, T., Simonson, M.S., High glucose evokes an intrinsic proapoptotic signaling pathway in mesangial cells. Kidney Int. 67:1 (2005), 82–93.
27. [27] Jiang, T., Huang, Z., Lin, Y., Zhang, Z., Fang, D., Zhang, D.D., The protective role of Nrf2 in streptozotocin-induced diabetic nephropathy. Diabetes 59:4 (2010), 850–860.
28. [28] Liu, C.M., Qi, X.L., Yang, Y.F., Zhang, X.D., Betulinic acid inhibits cell proliferation and fibronectin accumulation in rat glomerular mesangial cells cultured under high glucose condition. Biomed. Pharmacother. 80 (2016), 338–342.
29. [29] Chan, T.M., Leung, J.K., Tsang, R.C., Liu, Z.H., Li, L.S., Yung, S., Emodin ameliorates glucose-induced matrix synthesis in human peritoneal mesothelial cells. Kidney Int. 64:2 (2003), 519–533.
30. [30] Ke, Y.Q., Liu, C., Hao, J.B., Lu, L., Lu, N.N., Wu, Z.K., et al. Morin inhibits cell proliferation and fibronectin accumulation in rat glomerular mesangial cells cultured under high glucose condition. Biomed. Pharmacother. 84 (2016), 622–627.
31. [31] Dang, J., Jia, R., Tu, Y., Xiao, S., Ding, G., Erythropoietin prevents reactive oxygen species generation and renal tubular cell apoptosis at high glucose leve. Biomed. Pharmacother. 64:10 (2010), 681–685.
32. [32] Oueslati, N., Charradi, K., Bedhiafi, T., Limam, F., Aouani, E., Protective effect of grape seed and skin extract against diabetes-induced oxidative stress and renal dysfunction in virgin and pregnant rat. Biomed. Pharmacother. 83 (2016), 584–592.
33. [33] Ha, H., Lee, H.B., Oxidative stress in diabetic nephropathy: basic and clinical information. Curr. Diab. Rep. 1:3 (2001), 282–287.
34. [34] Lee, H.B., Yu, M.R., Yang, Y., Jiang, Z., Ha, H., Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J. Am. Soc. Nephrol. 14:8 Suppl. 3 (2003), S241–S245.
35. [35] Kim, M.Y., Lim, J.H., Youn, H.H., Hong, Y.A., Yang, K.S., Park, H.S., et al. Resveratrol prevents renal lipotoxicity and inhibits mesangial cell glucotoxicity in a manner dependent on the AMPK-SIRT1-PGC1alpha axis in db/db mice. Diabetologia 56:1 (2013), 204–217.
36. [36] Jiang, Y., Cheng, D.W., Levi, E., Singh, L.P., IGF-1 increases laminin, cyclin D1, and p21Cip1 expression in glomerular mesangial cells: an investigation of the intracellular signaling pathway and cell-cycle progression. J. Cell. Biochem. 98:1 (2006), 208–220.
37. [37] Shi, Y., Ren, Y., Zhao, L., Du, C., Wang, Y., Zhang, Y., et al. Knockdown of thioredoxin interacting protein attenuates high glucose-induced apoptosis and activation of ASK1 in mouse mesangial cells. FEBS Lett. 585:12 (2011), 1789–1795.
38. [38] Lin, C.L., Wang, J.Y., Ko, J.Y., Surendran, K., Huang, Y.T., Kuo, Y.H., et al. Superoxide destabilization of beta-catenin augments apoptosis of high-glucose-stressed mesangial cells. Endocrinology 149:6 (2008), 2934–2942.
39. [39] Liang, J., Ge, F., Guo, C., Luo, G., Wang, X., Han, G., et al. Inhibition of PI3K/Akt partially leads to the inhibition of PrP(C)-induced drug resistance in gastric cancer cells. FEBS. J. 276:3 (2009), 685–694.